Key result
TEPP-46 alleviates RV failure in rats by promoting PKM2 tetramerization and mitochondrial network formation.
Why the study?
Right ventricle failure is not fully understood at the molecular level, and the detailed mechanisms by which PKM2 tetramerization alleviates heart failure remain unclear.
Does promoting PKM2 tetramerization with TEPP-46 improve right ventricular function and alleviate oxidative stress and apoptosis in a rat model of right ventricle failure?
Does promoting PKM2 tetramerization with TEPP-46 improve right ventricular function and alleviate oxidative stress and apoptosis in a rat model of right ventricle failure?
Answers are grounded in this paper and cite their sources.
Facilitating PKM2 tetramerization with TEPP-46 improves mitochondrial morphology, mitigates oxidative stress, and alleviates the progression of right ventricle failure in a preclinical model.
BACKGROUND: Right ventricle failure (RVF) is a progressive heart disease that has yet to be fully understood at the molecular level. Elevated M-type pyruvate kinase 2 (PKM2) tetramerization alleviates heart failure, but detailed molecular mechanisms remain unclear. OBJECTIVE: We observed changes in PKM2 tetramerization levels during the progression of right heart failure and in vitro cardiomyocyte hypertrophy and explored the causal relationship between altered PKM2 tetramerization and the imbalance of redox homeostasis in cardiomyocytes, as well as its underlying mechanisms. Ultimately, our goal was to propose rational intervention strategies for the treatment of RVF. METHOD: We established RVF in Sprague Dawley (SD) rats by intraperitoneal injection of monocrotaline (MCT). The pulmonary artery pressure and right heart function of rats were assessed using transthoracic echocardiography combined with right heart catheterization. TEPP-46 was used both in vivo and in vitro to promote PKM2 tetramerization. RESULTS: We observed that oxidative stress and mitochondrial disorganization were associated with increased apoptosis in the right ventricular tissue of RVF rats. Quantitative proteomics revealed that PKM2 was upregulated during RVF and negatively correlated with the cardiac function. Facilitating PKM2 tetramerization promoted mitochondrial network formation and alleviated oxidative stress and apoptosis during cardiomyocyte hypertrophy. Moreover, enhancing PKM2 tetramer formation improved cardiac mitochondrial morphology, mitigated oxidative stress and alleviated heart failure. CONCLUSION: Disruption of PKM2 tetramerization contributed to RVF by inducing mitochondrial fragmentation, accumulating ROS, and finally promoted the progression of cardiomyocyte apoptosis. Facilitating PKM2 tetramerization holds potential as a promising therapeutic approach for RVF.
No takes yet. Share an insight, caveat, or question.
Guo et al. (2023) studied Right ventricular failure. TEPP-46 vs. Solvent control was evaluated on Right ventricular function, apoptosis, and mitochondrial morphology. Promoting PKM2 tetramerization with TEPP-46 improved mitochondrial network formation, mitigated oxidative stress, and alleviated the deterioration of cardiac function in a rat model of right ventricular failure.
Synapse has enriched 10 related papers. Consider them for comparative context: